Structure and Function of an Fc Receptor for IgA and IgM
IgA 和 IgM Fc 受体的结构和功能
基本信息
- 批准号:7018461
- 负责人:
- 金额:$ 28.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-02-15 至 2009-01-31
- 项目状态:已结题
- 来源:
- 关键词:B lymphocyteantibody receptorantibody specificityantigen presentationbinding sitescell population studyclinical researchdendritic cellsgene expressiongene targetinggenetic modelsgenetically modified animalshuman subjectimmune responseimmunoglobulin Aimmunoglobulin Mlaboratory mouselaboratory rabbitmessenger RNAprotein quantitation /detectionprotein structure functionreceptor mediated endocytosissolubilityspecies differencetransfection
项目摘要
DESCRIPTION (provided by applicant): The overall goal of these studies is to define the structure/function relationship of a recently identified Fc receptor for IgA and IgM (Fcalpha/muR). The Ig-like domain at the amino terminus of the predicted Fcalpha/muR glycoprotein contains a sequence motif that is conserved in the polymeric Ig receptor of various species and is predicted to be the binding site for IgM and IgA. The Fcalpha/muR gene is expressed in both hematopoietic (B and monocyte/macrophages) and non-hematopoietic (kidney and intestine) tissues in both humans and mice. Preliminary studies of Fcalpha/muR expression in humans indicate an interesting cellular distribution: germinal centers with the appearance of follicular dendritic cells (FDC) in tonsil, proximal tubular epithelial cells in kidney and Paneth cells in small intestinal crypts. Unlike the mouse Fcalpha/muR, the human receptor is expressed only by the B cells that reside in secondary lymphoid tissues rather than those present in the circulation. A novel splice variant that is predicted to encode a soluble form of Fcalpha/muR has been identified in the kidney. These findings have led to the hypothesis that Fcalpha/muR plays multiple functional roles depending upon the cell types expressing it. Fcalpha/muR on FDC may trap IgM or IgA immune complexes and present the intact antigens to B cells in germinal centers. Fcalpha/muR expression by B cells may be closely linked with cellular activation. On the other hand, Fcalpha/muR in renal tubular epithelial cells and intestinal Paneth cells may play a protective role at portals of entry for antigens and microorganisms. These hypotheses will be tested through the following Specific Aims: 1) Determine the cellular distribution and molecular nature of Fcalpha/muR by using receptor-specific antibodies and Ig-ligands; 2) Define the newly identified Fcalpha/muR splice variant as a soluble form of receptor; 3) Determine the function of the membrane-bound Fcalpha/muR; and 4) Employ an Fcalpha/muR-deficient mouse model to explore the in vivo function of the Fca/alphaR.
描述(申请人提供):这些研究的总体目标是确定最近发现的免疫球蛋白A和免疫球蛋白M的Fc受体(Fcalpha/MUR)的结构/功能关系。预测的Fcalpha/MUR糖蛋白氨基末端的Ig样结构域包含一个序列基序,该基序在不同物种的聚合Ig受体中保守,被预测为IgM和IgA的结合部位。Fcalpha/mur基因在人类和小鼠的造血系(B细胞和单核/巨噬细胞)和非造血系(肾和肠)组织中都有表达。对Fcalpha/MUR在人类中表达的初步研究表明,在人类中有一种有趣的细胞分布:扁桃体中出现滤泡树突状细胞(FDC)的生发中心,肾脏中的近端肾小管上皮细胞和小肠隐窝中的Paneth细胞。与小鼠Fcalpha/MUR不同,人类受体只由次级淋巴组织中的B细胞表达,而不是循环中的B细胞。在肾脏中发现了一种新的剪接变异体,被预测编码一种可溶性形式的Fcalpha/mur。这些发现导致了一种假设,即Fcalpha/MUR根据表达它的细胞类型而发挥多种功能。FDC上的Fcalpha/MUR可捕获IgM或IgA免疫复合物,并将完整的抗原呈递给生发中心的B细胞。B细胞表达Fcalpha/mur可能与细胞活化密切相关。另一方面,肾小管上皮细胞和肠道Paneth细胞中的Fcalpha/MUR可能在抗原和微生物进入的入口起到保护作用。这些假说将通过下列具体目标得到验证:1)通过使用受体特异性抗体和Ig配体来确定Fcalpha/MUR的细胞分布和分子性质;2)将新发现的Fcalpha/MUR剪接变体定义为一种可溶形式的受体;3)确定膜结合的Fcalpha/MUR的功能;以及4)利用Fcalpha/MUR缺陷小鼠模型来探索FCA/AlphaR在体内的功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hiromi Kubagawa其他文献
Hiromi Kubagawa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hiromi Kubagawa', 18)}}的其他基金
Studies of Paired Immunoglobulin-Like Receptors
配对免疫球蛋白样受体的研究
- 批准号:
8082003 - 财政年份:2010
- 资助金额:
$ 28.32万 - 项目类别:
Studies of structure and function of an Fc receptor for IgM
IgM Fc 受体的结构和功能研究
- 批准号:
8091880 - 财政年份:2010
- 资助金额:
$ 28.32万 - 项目类别:
Structure and Function of an Fc Receptor for IgA and IgM
IgA 和 IgM Fc 受体的结构和功能
- 批准号:
7340730 - 财政年份:2004
- 资助金额:
$ 28.32万 - 项目类别:
Structure and Function of an Fc Receptor for IgA and IgM
IgA 和 IgM Fc 受体的结构和功能
- 批准号:
7179263 - 财政年份:2004
- 资助金额:
$ 28.32万 - 项目类别:
Structure and Function of an Fc Receptor for IgA and IgM
IgA 和 IgM Fc 受体的结构和功能
- 批准号:
6773549 - 财政年份:2004
- 资助金额:
$ 28.32万 - 项目类别:
Structure and Function of an Fc Receptor for IgA and IgM
IgA 和 IgM Fc 受体的结构和功能
- 批准号:
6850789 - 财政年份:2004
- 资助金额:
$ 28.32万 - 项目类别:
NOVEL PAIR OF IMMUNOGLOBULIN LIKE RECEPTORS IN MICE
小鼠体内的一对新型免疫球蛋白样受体
- 批准号:
6510761 - 财政年份:1998
- 资助金额:
$ 28.32万 - 项目类别:
NOVEL PAIR OF IMMUNOGLOBULIN LIKE RECEPTORS IN MICE
小鼠体内的一对新型免疫球蛋白样受体
- 批准号:
2887625 - 财政年份:1998
- 资助金额:
$ 28.32万 - 项目类别:
相似海外基金
Study on the mechanism of prolonged half-life of blood IgY by unique antibody receptor and its application to immune enhancement in birds
独特抗体受体延长血液IgY半衰期的机制研究及其在禽类免疫增强中的应用
- 批准号:
23H02361 - 财政年份:2023
- 资助金额:
$ 28.32万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Innate immune functions of the intracellular antibody receptor TRIM21
细胞内抗体受体 TRIM21 的先天免疫功能
- 批准号:
nhmrc : GNT1124162 - 财政年份:2017
- 资助金额:
$ 28.32万 - 项目类别:
Early Career Fellowships
Innate immune functions of the intracellular antibody receptor TRIM21
细胞内抗体受体 TRIM21 的先天免疫功能
- 批准号:
nhmrc : 1124162 - 财政年份:2017
- 资助金额:
$ 28.32万 - 项目类别:
Early Career Fellowships
Mechanism and engineering of IgG-based monoclonal antibody/receptor interactions
基于 IgG 的单克隆抗体/受体相互作用的机制和工程
- 批准号:
9300976 - 财政年份:2015
- 资助金额:
$ 28.32万 - 项目类别:
Mechanism and engineering of IgG-based monoclonal antibody/receptor interactions
基于 IgG 的单克隆抗体/受体相互作用的机制和工程
- 批准号:
9920805 - 财政年份:2015
- 资助金额:
$ 28.32万 - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8900121 - 财政年份:2012
- 资助金额:
$ 28.32万 - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8225814 - 财政年份:2012
- 资助金额:
$ 28.32万 - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8699511 - 财政年份:2012
- 资助金额:
$ 28.32万 - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8525355 - 财政年份:2012
- 资助金额:
$ 28.32万 - 项目类别:
Small Grants for Exploratory Research: Separation of Cells and Biological Macromolecules by Antibody Receptor Coated Magnetic Vesicles and Ferritin Conjugates
探索性研究小额资助:通过抗体受体包被的磁囊和铁蛋白缀合物分离细胞和生物大分子
- 批准号:
9115537 - 财政年份:1991
- 资助金额:
$ 28.32万 - 项目类别:
Standard Grant